0001104659-24-059336.txt : 20240509 0001104659-24-059336.hdr.sgml : 20240509 20240509161516 ACCESSION NUMBER: 0001104659-24-059336 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240508 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TACTILE SYSTEMS TECHNOLOGY INC CENTRAL INDEX KEY: 0001027838 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37799 FILM NUMBER: 24930851 BUSINESS ADDRESS: STREET 1: 1331 TYLER STREET NE STE 200 CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 866-435-3948 MAIL ADDRESS: STREET 1: 1331 TYLER STREET NE STE 200 CITY: MINNEAPOLIS STATE: MN ZIP: 55413 8-K 1 tm2413966d1_8k.htm FORM 8-K
false --12-31 0001027838 0001027838 2024-05-08 2024-05-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 8, 2024

 

TACTILE SYSTEMS TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37799   41-1801204
(State or other jurisdiction of   (Commission   (IRS Employer
incorporation)   File Number)   Identification No.)

 

3701 Wayzata Blvd, Suite 300, Minneapolis, MN 55416

(Address of principal executive offices) (Zip Code)

 

(612) 355-5100

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which
registered
Common Stock, Par Value $0.001 Per Share TCMD The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  ¨ Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

  

 

 

 

Item 5.03.Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

 

As further described below in Item 5.07 of this Current Report on Form 8-K, on May 8, 2024, at the Annual Meeting of Stockholders of Tactile Systems Technology, Inc. (the “Company”), the Company’s stockholders approved an amendment (the “Exculpation Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to allow for exculpation of the Company’s officers from liability in specific circumstances. On May 8, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation that sets forth the Exculpation Amendment (the “Certificate of Amendment”).

 

A description of the Exculpation Amendment is set forth in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 27, 2024 (the “Proxy Statement”) in the section entitled “Proposal 4 - Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Allow for Exculpation of Officers as Permitted by Delaware Law.” The foregoing description of the Exculpation Amendment is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 5.07.Submission of Matters to a Vote of Security Holders

 

On May 8, 2024, the Company held its 2024 Annual Meeting of Stockholders and the Company’s stockholders voted on the following matters:

 

Election of Directors

 

The following nominees were elected to serve as directors for a term that will last until the Company’s 2025 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows:

 

Name Votes For Votes Withheld Broker Non-Votes
Valerie L. Asbury 17,781,587 442,062 2,616,580
William W. Burke 17,801,596 422,053 2,616,580
Sheri L. Dodd 17,874,433 349,216 2,616,580
Raymond O. Huggenberger 17,801,042 422,607 2,616,580
Daniel L. Reuvers 17,867,596 356,053 2,616,580
D. Brent Shafer 17,838,149 385,500 2,616,580
Carmen B. Volkart 17,838,867 384,782 2,616,580
B. Vindell Washington 18,036,704 186,945 2,616,580

 

Ratification of the Selection of Grant Thornton LLP as the Company’s Independent Auditor for 2024

 

The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024 by voting as follows:

 

For Against Abstain Broker Non-Votes
20,705,430 112,433 22,366 0

 

Advisory Vote on Approval of the Compensation of the Company’s Named Executive Officers

 

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by voting as follows:

 

For Against Abstain Broker Non-Votes
17,781,574 419,547 22,528 2,616,580

 

 

 

 

Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation to Allow for Exculpation of Officers as permitted by Delaware Law

 

The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to allow for exculpation of officers as permitted by Delaware law by voting as follows:

 

For Against Abstain Broker Non-Votes
17,296,464 913,066 14,119 2,616,580

 

Item 9.01.Financial Statements and Exhibits

 

(d) Exhibits

 

EXHIBIT INDEX

 

Exhibit
No.
  Description
     
3.1   Certificate of Amendment to Amended and Restated Certificate of Incorporation, dated May 8, 2024
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TACTILE SYSTEMS TECHNOLOGY, INC.
   
Date: May 9, 2024 By: /s/ Elaine M. Birkemeyer
    Elaine M. Birkemeyer
    Chief Financial Officer

 

 

 

EX-3.1 2 tm2413966d1_ex3-1.htm EXHIBIT 3.1

 

Exhibit 3.1

 

CERTIFICATE OF AMENDMENT TO THE

CERTIFICATE OF INCORPORATION OF

TACTILE SYSTEMS TECHNOLOGY, INC.

 

Tactile Systems Technology, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), hereby certifies as follows:

 

FIRST: At a meeting of the Board of Directors of the Corporation, the Board of Directors approved a proposed amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) of the Corporation.

 

SECOND: The proposed amendment provides that the heading of Article 8, and Section 8.1, of the Certificate of Incorporation is hereby amended to read in its entirety as follows:

 

ARTICLE 8
DIRECTOR AND OFFICER LIABILITY; INDEMNIFICATION AND INSURANCE

 

8.1Elimination of Certain Liability of Directors and Officers. The personal liability of the directors and the officers of the Corporation shall be eliminated to the fullest extent permitted by law. If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors or officers, then the liability of a director or an officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.

 

THIRD: Pursuant to Section 242 of the General Corporation Law of the State of Delaware, at the Corporation’s 2024 annual meeting of stockholders, duly called and held, the necessary number of shares as required by statute were voted in favor of the amendment.

 

FOURTH: The foregoing amendment was duly adopted in accordance with Section 242 of the General Corporation Law of the State of Delaware.

 

FIFTH: The foregoing amendment shall be effective on the date this Certificate of Amendment is filed with the Secretary of State of the State of Delaware.

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by the authorized officer named below, this 8th day of May, 2024.

 

 TACTILE SYSTEMS TECHNOLOGY, INC. 
  
 By: /s/ Elaine M. Birkemeyer 
   Elaine M. Birkemeyer 
   Chief Financial Officer 

 

 

 

EX-101.SCH 3 tcmd-20240508.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 tcmd-20240508_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 tcmd-20240508_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
May 08, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 08, 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-37799
Entity Registrant Name TACTILE SYSTEMS TECHNOLOGY, INC.
Entity Central Index Key 0001027838
Entity Tax Identification Number 41-1801204
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 3701 Wayzata Blvd
Entity Address, Address Line Two Suite 300
Entity Address, City or Town Minneapolis
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55416
City Area Code 612
Local Phone Number 355-5100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, Par Value $0.001 Per Share
Trading Symbol TCMD
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://tactilemedical.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tcmd-20240508.xsd tcmd-20240508_lab.xml tcmd-20240508_pre.xml tm2413966d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2413966d1_8k.htm": { "nsprefix": "TCMD", "nsuri": "http://tactilemedical.com/20240508", "dts": { "schema": { "local": [ "tcmd-20240508.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "tcmd-20240508_lab.xml" ] }, "presentationLink": { "local": [ "tcmd-20240508_pre.xml" ] }, "inline": { "local": [ "tm2413966d1_8k.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://tactilemedical.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2413966d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2413966d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://tactilemedical.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-059336-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-059336-xbrl.zip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end XML 17 tm2413966d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001027838 2024-05-08 2024-05-08 iso4217:USD shares iso4217:USD shares false --12-31 0001027838 8-K 2024-05-08 TACTILE SYSTEMS TECHNOLOGY, INC. DE 001-37799 41-1801204 3701 Wayzata Blvd Suite 300 Minneapolis MN 55416 612 355-5100 false false false false Common Stock, Par Value $0.001 Per Share TCMD NASDAQ false